These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19431172)

  • 1. Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis.
    Ullrich A; Chai Y; Pistorius D; Elnakady YA; Herrmann JE; Weissman KJ; Kazmaier U; Müller R
    Angew Chem Int Ed Engl; 2009; 48(24):4422-5. PubMed ID: 19431172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 23 natural tubulysins from Angiococcus disciformis An d48 and Cystobacter SBCb004.
    Chai Y; Pistorius D; Ullrich A; Weissman KJ; Kazmaier U; Müller R
    Chem Biol; 2010 Mar; 17(3):296-309. PubMed ID: 20338521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria.
    Khalil MW; Sasse F; Lünsdorf H; Elnakady YA; Reichenbach H
    Chembiochem; 2006 Apr; 7(4):678-83. PubMed ID: 16491500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physico-chemical and biological properties.
    Sasse F; Steinmetz H; Heil J; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 2000 Sep; 53(9):879-85. PubMed ID: 11099220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and analysis of the core biosynthetic machinery of tubulysin, a potent cytotoxin with potential anticancer activity.
    Sandmann A; Sasse F; Müller R
    Chem Biol; 2004 Aug; 11(8):1071-9. PubMed ID: 15324808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and antitumor activity evaluation of pretubulysin analogs.
    Xu X; Fan M; Qi J; Yao L
    Chem Biol Drug Des; 2021 Sep; 98(3):341-351. PubMed ID: 33930251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First total synthesis of tubulysin B.
    Pando O; Dörner S; Preusentanz R; Denkert A; Porzel A; Richter W; Wessjohann L
    Org Lett; 2009 Dec; 11(24):5567-9. PubMed ID: 19919080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
    Herrmann J; Elnakady YA; Wiedmann RM; Ullrich A; Rohde M; Kazmaier U; Vollmar AM; Müller R
    PLoS One; 2012; 7(5):e37416. PubMed ID: 22616003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic simplified tubulysin analogues.
    Raghavan B; Balasubramanian R; Steele JC; Sackett DL; Fecik RA
    J Med Chem; 2008 Mar; 51(6):1530-3. PubMed ID: 18314944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid mediated formation of an N-acyliminium ion from tubulysins: a new methodology for the synthesis of natural tubulysins and their analogs.
    Vlahov IR; Wang Y; Vetzel M; Hahn S; Kleindl PJ; Reddy JA; Leamon CP
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6778-81. PubMed ID: 21974954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of tubulysin U and its C-4 epimer.
    Yang XD; Dong CM; Chen J; Ding YH; Liu Q; Ma XY; Zhang Q; Chen Y
    Chem Asian J; 2013 Jun; 8(6):1213-22. PubMed ID: 23576385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo structural activity and optimization studies of folate-tubulysin conjugates.
    Reddy JA; Dorton R; Dawson A; Vetzel M; Parker N; Nicoson JS; Westrick E; Klein PJ; Wang Y; Vlahov IR; Leamon CP
    Mol Pharm; 2009; 6(5):1518-25. PubMed ID: 19630399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of tubulysin D analogs related to stereoisomers of tubuvaline.
    Shibue T; Okamoto I; Morita N; Morita H; Hirasawa Y; Hosoya T; Tamura O
    Bioorg Med Chem Lett; 2011 Jan; 21(1):431-4. PubMed ID: 21106374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
    Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
    J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic oligopeptides with chlorambucil moiety--synthesis and biological evaluation.
    Bartulewicz D
    Acta Pol Pharm; 2005; 62(6):451-5. PubMed ID: 16583984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of the putative structure of lucentamycin A.
    Pal U; Ranatunga S; Ariyarathna Y; Del Valle JR
    Org Lett; 2009 Nov; 11(22):5298-301. PubMed ID: 19863114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
    Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified pretubulysin derivatives and their biological effects on cancer cells.
    Kubisch R; von Gamm M; Braig S; Ullrich A; Burkhart JL; Colling L; Hermann J; Scherer O; Müller R; Werz O; Kazmaier U; Vollmar AM
    J Nat Prod; 2014 Mar; 77(3):536-42. PubMed ID: 24437936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new cytotoxic spiroketal from the myxobacterium Sorangium cellulosum.
    Kwak JH; Ahn JW
    Arch Pharm Res; 2009 Jun; 32(6):841-4. PubMed ID: 19557360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological properties of highly potent tubulysin D analogues.
    Patterson AW; Peltier HM; Sasse F; Ellman JA
    Chemistry; 2007; 13(34):9534-41. PubMed ID: 17828721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.